This bill amends the New Mexico Controlled Substances Act to align the scheduling of crystalline polymorph psilocybin with federal law. Specifically, it introduces a new provision stating that upon the rescheduling of crystalline polymorph psilocybin by the United States Food and Drug Administration, it will be automatically scheduled and listed in accordance with federal regulations. This change is intended to ensure that state law reflects any updates made at the federal level regarding the classification of this substance.

Additionally, the bill modifies the existing Schedule I controlled substances list to include a specific reference to psilocybin, but clarifies that this inclusion is contingent upon its rescheduling by the FDA. The amendments aim to streamline the process of regulating psilocybin in New Mexico, ensuring that state law remains consistent with federal guidelines while addressing the evolving landscape of controlled substances.

Statutes affected:
introduced version: 30-31-3, 30-31-6